I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Infection Surveillance Solutions Market on a Rapid Growth
Trajectory
Cloud-based Infection Surveillance Solutions Witness Increased
Demand
Asia-Pacific to be Fastest Growing Region, Driven by Increasing
Cases of HAIs
Global Competitor Market Shares
Infection Surveillance Solutions Competitor Market Share
Scenario Worldwide (in %): 2019 & 2025
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS
Growing Incidence of HAIs, and Government Measures to Control
them Drive the Growth of Infection Surveillance Solutions
Market
Increasing Emphasis on Controlling Healthcare Expenditure
Propels the Infection Surveillance Solutions Market
Rise in Number of Surgeries to Increase the Chances of HAI,
thereby Driving the Demand for Infection Surveillance
Solutions
Increasing Automation in Healthcare Units Offer Significant
Opportunities for Market Growth

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Infection
Surveillance Solutions by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027

Table 2: World 7-Year Perspective for Infection Surveillance
Solutions by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets for Years 2020 & 2027

Table 3: World Current & Future Analysis for Software by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027

Table 4: World 7-Year Perspective for Software by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2020 & 2027

Table 5: World Current & Future Analysis for Services by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027

Table 6: World 7-Year Perspective for Services by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2020 & 2027

Table 7: World Current & Future Analysis for Hospitals by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027

Table 8: World 7-Year Perspective for Hospitals by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2020 & 2027

Table 9: World Current & Future Analysis for Long-term Care
Facilities by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027

Table 10: World 7-Year Perspective for Long-term Care
Facilities by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World for Years 2020 & 2027

Table 11: World Current & Future Analysis for Other End-Uses by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027

Table 12: World 7-Year Perspective for Other End-Uses by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2020 & 2027

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES
Market Facts & Figures
US Infection Surveillance Solutions Market Share (in %) by
Company: 2019 & 2025
Market Analytics
Table 13: USA Current & Future Analysis for Infection
Surveillance Solutions by Product - Software and Services -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027

Table 14: USA 7-Year Perspective for Infection Surveillance
Solutions by Product - Percentage Breakdown of Value Sales for
Software and Services for the Years 2020 & 2027

Table 15: USA Current & Future Analysis for Infection
Surveillance Solutions by End-Use - Hospitals, Long-term Care
Facilities and Other End-Uses - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027

Table 16: USA 7-Year Perspective for Infection Surveillance
Solutions by End-Use - Percentage Breakdown of Value Sales for
Hospitals, Long-term Care Facilities and Other End-Uses for the
Years 2020 & 2027

CANADA
Table 17: Canada Current & Future Analysis for Infection
Surveillance Solutions by Product - Software and Services -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027

Table 18: Canada 7-Year Perspective for Infection Surveillance
Solutions by Product - Percentage Breakdown of Value Sales for
Software and Services for the Years 2020 & 2027

Table 19: Canada Current & Future Analysis for Infection
Surveillance Solutions by End-Use - Hospitals, Long-term Care
Facilities and Other End-Uses - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027

Table 20: Canada 7-Year Perspective for Infection Surveillance
Solutions by End-Use - Percentage Breakdown of Value Sales for
Hospitals, Long-term Care Facilities and Other End-Uses for the
Years 2020 & 2027

JAPAN
Table 21: Japan Current & Future Analysis for Infection
Surveillance Solutions by Product - Software and Services -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027

Table 22: Japan 7-Year Perspective for Infection Surveillance
Solutions by Product - Percentage Breakdown of Value Sales for
Software and Services for the Years 2020 & 2027

Table 23: Japan Current & Future Analysis for Infection
Surveillance Solutions by End-Use - Hospitals, Long-term Care
Facilities and Other End-Uses - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027

Table 24: Japan 7-Year Perspective for Infection Surveillance
Solutions by End-Use - Percentage Breakdown of Value Sales for
Hospitals, Long-term Care Facilities and Other End-Uses for the
Years 2020 & 2027

CHINA
Table 25: China Current & Future Analysis for Infection
Surveillance Solutions by Product - Software and Services -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027

Table 26: China 7-Year Perspective for Infection Surveillance
Solutions by Product - Percentage Breakdown of Value Sales for
Software and Services for the Years 2020 & 2027

Table 27: China Current & Future Analysis for Infection
Surveillance Solutions by End-Use - Hospitals, Long-term Care
Facilities and Other End-Uses - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027

Table 28: China 7-Year Perspective for Infection Surveillance
Solutions by End-Use - Percentage Breakdown of Value Sales for
Hospitals, Long-term Care Facilities and Other End-Uses for the
Years 2020 & 2027

EUROPE
Market Facts & Figures
European Infection Surveillance Solutions Market: Competitor
Market Share Scenario (in %) for 2019 & 2025
Market Analytics
Table 29: Europe Current & Future Analysis for Infection
Surveillance Solutions by Geographic Region - France, Germany,
Italy, UK and Rest of Europe Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2020 through 2027

Table 30: Europe 7-Year Perspective for Infection Surveillance
Solutions by Geographic Region - Percentage Breakdown of Value
Sales for France, Germany, Italy, UK and Rest of Europe Markets
for Years 2020 & 2027

Table 31: Europe Current & Future Analysis for Infection
Surveillance Solutions by Product - Software and Services -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027

Table 32: Europe 7-Year Perspective for Infection Surveillance
Solutions by Product - Percentage Breakdown of Value Sales for
Software and Services for the Years 2020 & 2027

Table 33: Europe Current & Future Analysis for Infection
Surveillance Solutions by End-Use - Hospitals, Long-term Care
Facilities and Other End-Uses - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027

Table 34: Europe 7-Year Perspective for Infection Surveillance
Solutions by End-Use - Percentage Breakdown of Value Sales for
Hospitals, Long-term Care Facilities and Other End-Uses for the
Years 2020 & 2027

FRANCE
Table 35: France Current & Future Analysis for Infection
Surveillance Solutions by Product - Software and Services -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027

Table 36: France 7-Year Perspective for Infection Surveillance
Solutions by Product - Percentage Breakdown of Value Sales for
Software and Services for the Years 2020 & 2027

Table 37: France Current & Future Analysis for Infection
Surveillance Solutions by End-Use - Hospitals, Long-term Care
Facilities and Other End-Uses - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027

Table 38: France 7-Year Perspective for Infection Surveillance
Solutions by End-Use - Percentage Breakdown of Value Sales for
Hospitals, Long-term Care Facilities and Other End-Uses for the
Years 2020 & 2027

GERMANY
Table 39: Germany Current & Future Analysis for Infection
Surveillance Solutions by Product - Software and Services -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027

Table 40: Germany 7-Year Perspective for Infection Surveillance
Solutions by Product - Percentage Breakdown of Value Sales for
Software and Services for the Years 2020 & 2027

Table 41: Germany Current & Future Analysis for Infection
Surveillance Solutions by End-Use - Hospitals, Long-term Care
Facilities and Other End-Uses - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027

Table 42: Germany 7-Year Perspective for Infection Surveillance
Solutions by End-Use - Percentage Breakdown of Value Sales for
Hospitals, Long-term Care Facilities and Other End-Uses for the
Years 2020 & 2027

ITALY
Table 43: Italy Current & Future Analysis for Infection
Surveillance Solutions by Product - Software and Services -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027

Table 44: Italy 7-Year Perspective for Infection Surveillance
Solutions by Product - Percentage Breakdown of Value Sales for
Software and Services for the Years 2020 & 2027

Table 45: Italy Current & Future Analysis for Infection
Surveillance Solutions by End-Use - Hospitals, Long-term Care
Facilities and Other End-Uses - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027

Table 46: Italy 7-Year Perspective for Infection Surveillance
Solutions by End-Use - Percentage Breakdown of Value Sales for
Hospitals, Long-term Care Facilities and Other End-Uses for the
Years 2020 & 2027

UNITED KINGDOM
Table 47: UK Current & Future Analysis for Infection
Surveillance Solutions by Product - Software and Services -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027

Table 48: UK 7-Year Perspective for Infection Surveillance
Solutions by Product - Percentage Breakdown of Value Sales for
Software and Services for the Years 2020 & 2027

Table 49: UK Current & Future Analysis for Infection
Surveillance Solutions by End-Use - Hospitals, Long-term Care
Facilities and Other End-Uses - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027

Table 50: UK 7-Year Perspective for Infection Surveillance
Solutions by End-Use - Percentage Breakdown of Value Sales for
Hospitals, Long-term Care Facilities and Other End-Uses for the
Years 2020 & 2027

REST OF EUROPE
Table 51: Rest of Europe Current & Future Analysis for
Infection Surveillance Solutions by Product - Software and
Services - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027

Table 52: Rest of Europe 7-Year Perspective for Infection
Surveillance Solutions by Product - Percentage Breakdown of
Value Sales for Software and Services for the Years 2020 & 2027

Table 53: Rest of Europe Current & Future Analysis for
Infection Surveillance Solutions by End-Use - Hospitals,
Long-term Care Facilities and Other End-Uses - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027

Table 54: Rest of Europe 7-Year Perspective for Infection
Surveillance Solutions by End-Use - Percentage Breakdown of
Value Sales for Hospitals, Long-term Care Facilities and Other
End-Uses for the Years 2020 & 2027

ASIA-PACIFIC
Table 55: Asia-Pacific Current & Future Analysis for Infection
Surveillance Solutions by Product - Software and Services -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027

Table 56: Asia-Pacific 7-Year Perspective for Infection
Surveillance Solutions by Product - Percentage Breakdown of
Value Sales for Software and Services for the Years 2020 & 2027

Table 57: Asia-Pacific Current & Future Analysis for Infection
Surveillance Solutions by End-Use - Hospitals, Long-term Care
Facilities and Other End-Uses - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027

Table 58: Asia-Pacific 7-Year Perspective for Infection
Surveillance Solutions by End-Use - Percentage Breakdown of
Value Sales for Hospitals, Long-term Care Facilities and Other
End-Uses for the Years 2020 & 2027

REST OF WORLD
Table 59: Rest of World Current & Future Analysis for Infection
Surveillance Solutions by Product - Software and Services -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027

Table 60: Rest of World 7-Year Perspective for Infection
Surveillance Solutions by Product - Percentage Breakdown of
Value Sales for Software and Services for the Years 2020 & 2027

Table 61: Rest of World Current & Future Analysis for Infection
Surveillance Solutions by End-Use - Hospitals, Long-term Care
Facilities and Other End-Uses - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027

Table 62: Rest of World 7-Year Perspective for Infection
Surveillance Solutions by End-Use - Percentage Breakdown of
Value Sales for Hospitals, Long-term Care Facilities and Other
End-Uses for the Years 2020 & 2027

IV. COMPETITION
Total Companies Profiled: 41